The switch is usually made for patient preference (avoiding injections) rather than clinical superiority
Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg for 4 weeks, then increased by 2.5 mg every 4 weeks until the recommended maintenance dose (5 mg, 10 mg, or 15 mg once weekly) is reached based on individual tolerance and therapeutic response
We can develop a combined protocol aligned with your goals
Freezing is equally damaging and immediately renders the medication unusable
Elevated cortisol promotes fat storage, increases insulin resistance, and stimulates appetite through pathways that partially bypass GLP-1 signaling
If you are experiencing shedding or want to take a proactive approach, schedule your Dallas dermatology appointment today.